Jürgen C. Becker

Prof. Dr. Dr. Jürgen C. Becker is a leading academic researcher in translational skin cancer research, affiliated with the University of Duisburg-Essen (Biological Faculty), the German Cancer Research Center (DKFZ), and the West German Cancer Center (WTZ) in Essen. He leads a research group focused on understanding tumor biology and immunology in skin cancers, particularly melanoma and Merkel cell carcinoma, using cutting-edge multi-omics and spatial transcriptomics technologies.

His research interests span translational oncology, tumor microenvironment, cancer immunology, spatial transcriptomics, and biomarker discovery. He leverages patient-derived samples from low-interventional clinical trials and tissue registries to investigate tumor heterogeneity, immune evasion, and response to therapy. His work integrates advanced model systems with ex vivo analyses of FFPE tissues to bridge laboratory findings with clinical applications.

Recent publications highlight his focus on immunotherapy resistance mechanisms, T-cell dynamics, and the role of viral antigens in Merkel cell carcinoma. His team employs deep learning and Bayesian modeling to interpret complex datasets, aiming to identify novel therapeutic strategies such as early immunotherapy intervention and dual inhibition of DNA repair pathways.

Scientific contributions include high-impact studies published in Nature Communications, Clinical Cancer Research, Blood, and Cancer Research. While no formal awards or students are listed, his leadership in major consortia like DKTK and involvement in translational clinical programs underscore his significant role in advancing cancer research.

Prof. Becker is actively involved in mentoring and research leadership, overseeing a dynamic team engaged in prospective biosample collection, 3D tissue mapping via micro-CT, and multi-omic integration. His future work aims to explore the impact of endogenous retroviruses and the lesional microbiome on tumor progression, further pushing the boundaries of personalized oncology.